Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : NIFTY NINE IN NINETY NINE PLUS ONE -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (95)	1/7/1999 4:40:00 PM
From: Scott H. Davis	Read Replies (1) \| Respond to of 613

Yes, it's one of my 10, and one of my grins. I have 2 I consider speculative - BNTI and CTIC. CTIC had gotten hammered after a disappointment. Very based. A good item of clinical news & it should move up well. BNTI will either go broke or soar. They have items in tests, but no firm contracts. I saw AXPH as one of a group of several biotechs with good tech & partnering, that were hammer excessively last year. Lot of good potential picks, but I saw the 3 indiders buying & gave it the nod. Scott